Unrelated umbilical cord blood transplant for juvenile metachromatic leukodystrophy: a 5-year follow-up in three affected siblings

Mol Genet Metab. 2011 Feb;102(2):207-9. doi: 10.1016/j.ymgme.2010.10.002. Epub 2010 Oct 28.

Abstract

Unrelated umbilical cord blood transplantation (UCBT) was used to treat three siblings with juvenile metachromatic leukodystrophy (jMLD). The efficacy of this therapy was measured over a 5-year period with serial neurological examinations, neuroimaging, nerve conduction studies (NCS), and neuropsychological evaluations (NPE). Outcomes were a function of disease stage at time of UCBT with alteration of disease course occurring in the first 2 years after UCBT and then subsequent halting of progression and stabilization of symptoms and disease.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Brain / diagnostic imaging
  • Brain / enzymology
  • Brain / pathology
  • Cerebroside-Sulfatase / genetics
  • Cerebroside-Sulfatase / metabolism
  • Child
  • Child, Preschool
  • Cord Blood Stem Cell Transplantation*
  • Female
  • Follow-Up Studies
  • Humans
  • Leukodystrophy, Metachromatic / diagnosis
  • Leukodystrophy, Metachromatic / physiopathology
  • Leukodystrophy, Metachromatic / therapy*
  • Magnetic Resonance Imaging
  • Male
  • Radionuclide Imaging
  • Siblings
  • Treatment Outcome

Substances

  • Cerebroside-Sulfatase